News + Filings Holdings
|
BAILLIE GIFFORD & CO
> ADAP
Date | Name | Ticker | Shares | Change | Value | Change | Price |
06/30/2023 | Adaptimmune Therapeutics PLC | ADAP | 17,176,135 | 6,196 | 15,887,926,000 | -9,180,185,000 | $925.00 |
12/31/2022 | Adaptimmune Therapeutics PLC | ADAP | 17,169,939 | 1,848,593 | 25,068,111,000 | 25,042,065,000 | $1,460.00 |
06/30/2022 | Adaptimmune Therapeutics PLC | ADAP | 15,321,346 | -59,192 | 26,046,000 | -5,638,000 | $1.70 |
03/31/2022 | Adaptimmune Therapeutics PLC | ADAP | 15,380,538 | 1,624,186 | 31,684,000 | -19,903,000 | $2.06 |
12/31/2021 | Adaptimmune Therapeutics PLC | ADAP | 13,756,352 | 931,372 | 51,587,000 | -14,719,000 | $3.75 |
09/30/2021 | Adaptimmune Therapeutics PLC | ADAP | 12,824,980 | 1,128,061 | 66,306,000 | 16,478,000 | $5.17 |
06/30/2021 | Adaptimmune Therapeutics PLC | ADAP | 11,696,919 | 229,402 | 49,828,000 | -11,064,000 | $4.26 |
03/31/2021 | Adaptimmune Therapeutics PLC | ADAP | 11,467,517 | 1,109,737 | 60,892,000 | 5,064,000 | $5.31 |
12/31/2020 | Adaptimmune Therapeutics PLC | ADAP | 10,357,780 | 3,279,717 | 55,828,000 | -654,000 | $5.39 |
09/30/2020 | Adaptimmune Therapeutics PLC | ADAP | 7,078,063 | 1,788,394 | 56,482,000 | 3,532,000 | $7.98 |
06/30/2020 | Adaptimmune Therapeutics PLC | ADAP | 5,289,669 | 935,646 | 52,950,000 | 41,107,000 | $10.01 |
03/31/2020 | Adaptimmune Therapeutics PLC | ADAP | 4,354,023 | 66,478 | 11,843,000 | 6,698,000 | $2.72 |
12/31/2019 | Adaptimmune Therapeutics PLC | ADAP | 4,287,545 | 122,738 | 5,145,000 | -1,144,000 | $1.20 |
09/30/2019 | Adaptimmune Therapeutics PLC | ADAP | 4,164,807 | 20,967 | 6,289,000 | -10,369,000 | $1.51 |
06/30/2019 | Adaptimmune Therapeutics PLC | ADAP | 4,143,840 | 304,650 | 16,658,000 | 150,000 | $4.02 |
03/31/2019 | Adaptimmune Therapeutics PLC | ADAP | 3,839,190 | 139,669 | 16,508,000 | -4,764,000 | $4.30 |
12/31/2018 | Adaptimmune Therapeutics PLC | ADAP | 3,699,521 | 281,894 | 21,272,000 | -25,071,000 | $5.75 |
09/30/2018 | Adaptimmune Therapeutics PLC | ADAP | 3,417,627 | 384,366 | 46,343,000 | 10,338,000 | $13.56 |
06/30/2018 | Adaptimmune Therapeutics PLC | ADAP | 3,033,261 | 467,852 | 36,005,000 | 7,195,000 | $11.87 |
03/31/2018 | Adaptimmune Therapeutics PLC | ADAP | 2,565,409 | 644,816 | 28,810,000 | 15,981,000 | $11.23 |
12/31/2017 | Adaptimmune Therapeutics PLC | ADAP | 1,920,593 | 541,289 | 12,829,000 | 1,532,000 | $6.68 |
09/30/2017 | Adaptimmune Therapeutics PLC | ADAP | 1,379,304 | 55,996 | 11,297,000 | 5,356,000 | $8.19 |
06/30/2017 | Adaptimmune Therapeutics PLC | ADAP | 1,323,308 | 402,324 | 5,941,000 | 866,000 | $4.49 |
03/31/2017 | Adaptimmune Therapeutics PLC | ADAP | 920,984 | 0 | 5,075,000 | 1,345,000 | $5.51 |
12/31/2016 | Adaptimmune Therapeutics PLC | ADAP | 920,984 | 0 | 3,730,000 | -2,763,000 | $4.05 |
09/30/2016 | Adaptimmune Therapeutics PLC | ADAP | 920,984 | 920,984 | 6,493,000 | 6,493,000 | $7.05 |
06/30/2016 | Adaptimmune Therapeutics PLC | ADAP | 429,700 | 0 | 3,502,000 | 9,000 | $8.15 |
03/31/2016 | Adaptimmune Therapeutics PLC | ADAP | 429,700 | 429,700 | 3,493,000 | 3,493,000 | $8.13 |
<< Prev Next >> |
|